Aurobindo Pharma informs about board meeting

17 Jan 2025 Evaluate

Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed that a Meeting of the Board of Directors of the Company will be held on Thursday, February 6, 2025, to consider and approve, the Standalone & Consolidated Unaudited Financial Results of the Company for the third quarter and nine months period ended December 31, 2024. Further to its letter dated December 25, 2024, informing the closure of Trading Window of the Company from January 1, 2025, until 48 hours from the date of declaration of the Unaudited Financial Results of the Company for the third quarter and nine months period ended December 31, 2024, it has informed that the Trading Window will remain closed up to February 8, 2025, and shall be re-opened on February 9, 2025.

The above information is a part of company’s filings submitted to BSE.


Aurobindo Pharma Share Price

1217.45 -6.20 (-0.51%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×